Navigation Links
Statin Use Doesn't Inhibit Lymphoma Drug Therapy
Date:12/9/2008

Cholesterol-lowering meds may actually help patients on rituximab, study suggests

TUESDAY, Dec. 9 (HealthDay News) -- Cholesterol-lowering statin drugs don't interfere with rituximab, a medication used to treat lymphomas, say Mayo Clinic researchers, who also found that statins may actually slow progression of some kinds of lymphomas.

Rituximab is a monoclonal antibody often used alone or in conjunction with chemotherapy to treat lymphomas -- cancers of the lymph system. A study published earlier this year suggested that statins may inhibit rituximab's ability to bind to CD20, a protein found on lymphoma cells.

"That finding raised questions about maintaining or stopping cholesterol treatment with statins for patients with lymphoma," Mayo hematologist Dr. Grzegorz Nowakowski said in a clinic news release. "One in five lymphoma patients take cholesterol-lowering statins. This corresponds to the potential for thousands of patients at risk of getting less or ineffective treatment due to statin interference with therapy."

To clarify the issue, the Mayo team studied 228 patients with aggressive diffuse large B-cell lymphoma and 293 patients with slowly progressive follicular lymphoma. Twenty-two percent of the patients with diffuse large B-cell lymphoma and 19 percent of patients with follicular lymphoma were taking statins when they began treatment for their lymphoma.

Statin use didn't influence outcomes for patients with diffuse large B-cell lymphoma. Among the patients with follicular lymphoma, those taking statins actually had better outcomes. At two years, 80 percent of follicular lymphoma patients taking statins had no progression or re-treatment for their cancer, compared with 69 percent of patients not taking statins. This positive effect was observed regardless of the type of treatment: observation only; rituximab alone; or rituximab in combination with chemotherapy.

The study was expected to be presented Monday at the annual meeting of the American Society of Hematology, in San Francisco.

"These results can provide reassurance to oncologists and their patients that statins will not reduce the effectiveness of rituximab (brand name Rituxan) and may in fact improve outcomes of some patients with lymphomas," Nowakowski said.

More information

The Lymphoma Research Foundation has more about lymphoma.



-- Robert Preidt



SOURCE: Mayo Clinic, news release, Dec. 8, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Continued Statin Use Boosts Post-Stroke Outcomes
2. Stopping Statins After Stroke Doubles Death Risk
3. Research to shed new light on how statins benefit heart patients
4. A New Study Links High Volume Pain Pumps with the Devastating and Painful Loss of Cartilage Following Arthroscopic Shoulder Surgery
5. Statin Benefits Persist After Treatment Stops
6. Statins reduce loss of function, keeping old lungs young - even in smokers
7. Better Prostate Cancer Survival for Men Taking Statins
8. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
9. Congress called on to replace devastating cuts in Medicare reimbursements by ACP
10. Statins After Bypass Lower Stroke Risk
11. Burn injuries take devastating toll on nations children
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statin Use Doesn't  Inhibit  Lymphoma Drug Therapy
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology: